Qianxue Wang

Dr. Qianxue Wang

Academy of Military Medical Science
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2017 in Applied Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
HXHua Xiang
Hua Xiang
FCFengjiao Cao
Fengjiao Cao
DMDi Ming
Di Ming
YZYanyang Zheng
Yanyang Zheng
XDXiaoyun Dong
Xiaoyun Dong
QWQianxue Wang
Qianxue Wang

1 January 2019 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
HDHaisi Dong
Haisi Dong
HXHua Xiang
Hua Xiang
DMDan Mu
Dan Mu
QWQianxue Wang
Qianxue Wang
TWTiedong Wang
Tiedong Wang

16 October 2015 in Frontiers in Microbiology
Verified
Journal Article
Open access
LWLin Wang
Lin Wang
CBChongwei Bi
Chongwei Bi
HCHongjun Cai
Hongjun Cai
BLBingrun Liu
Bingrun Liu
XZXiaobo Zhong
Xiaobo Zhong
QWQianxue Wang
Qianxue Wang
The emergence and wide spread of multi-drug resistant Staphylococcus aureus (S. aureus) requires the development of new therapeutic agents with alternative modes of action. Anti-virulence strategies are hoped to meet that need. Sortase A (SrtA) has attracted great interest as a potential drug target to treat infections caused by S. aureus, as many of the surface proteins displayed by SrtA function as virulence factors by mediating bacterial adhesion to specific organ tissues, invasion of host cells, and evasion of the host-immune responses. It has been suggested that inhibitors of SrtA might be promising candidates for the treatment and/or prevention of S. aureus infections. In this study, we report that Chlorogenic acid (CHA), a natural compound that lacks significant anti–S. aureus activity, inhibit the activity of SrtA in vitro (IC50=33.86±5.55μg/ml) and the binding of S. aureus to fibrinogen (Fg). Using molecular dynamics simulations and mutagenesis assays, we further demonstrate that CHA binds to the binding sites of C184 and G192 in the SrtA. In vivo studies demonstrated that CHA prevent mice from S. aureus-induced renal abscess, resulting in a significant survival advantage. These findings indicate that CHA is a promising therapeutic compound against SrtA during S. aureus infections.

28 January 2019 in Molecules
Verified
Journal Article
Open access
PDF file
JWJunxian Wang
Junxian Wang
YSYan Shi
Yan Shi
SJShisong Jing
Shisong Jing
HDHaisi Dong
Haisi Dong
QWQianxue Wang
Qianxue Wang
TWTiedong Wang
Tiedong Wang
Streptococcus mutans (S. mutans) is the primary etiological agent of dental caries. The S. mutans enzyme sortase A (SrtA) is responsible for anchoring bacterial cell wall surface proteins involved in host cell attachment and biofilm formation. Thus, SrtA is an attractive target for inhibiting dental caries caused by S. mutans-associated acid fermentation. In this study, we observed that astilbin, a flavanone compound extracted from Rhizoma Smilacis Glabrae, has potent inhibitory activity against the S. mutans SrtA, with an IC50 of 7.5 μg/mL. In addition, astilbin was proven to reduce the formation of biofilm while without affecting the growth of S. mutans. The results of a molecular dynamics simulation and a mutation analysis revealed that the Arg213, Leu111, and Leu116 of SrtA are important for the interaction between SrtA and astilbin. The results of this study demonstrate the potential of using astilbin as a nonbactericidal agent to modulate pathogenicity of S. mutans by inhibiting the activity of SrtA.

9 August 2021 in Virulence
Verified
Journal Article
Open access
LWLi Wang
Li Wang
SJShisong Jing
Shisong Jing
HQHan Qu
Han Qu
KWKai Wang
Kai Wang
YJYajing Jin
Yajing Jin
QWQianxue Wang
Qianxue Wang
Drug-resistant pathogenic Staphylococcus aureus (S. aureus) has severely threatened human health and arouses widespread concern. Sortase A (SrtA) is an essential virulence factor of S. aureus, which is responsible for the covalent anchoring of a variety of virulence-related proteins to the cell wall. SrtA has always been regarded as an ideal pharmacological target against S. aureus infections. In this research, we have determined that orientin, a natural compound isolated from various medicinal plants, can effectively inhibit the activity of SrtA with an IC50 of 50.44 ± 0.51 µM. We further demonstrated that orientin inhibited the binding of S. aureus to fibrinogen and diminished biofilm formation and the attaching of Staphylococcal protein A (SpA) to the cell wall in vitro. Using the fluorescence quenching assay, we demonstrated a direct interaction between orientin and SrtA. Further mechanistic studies revealed that the residues Glu-105, Thr-93, and Cys-184 were the key sites for the binding of SrtA to orientin. Importantly, we demonstrated that treatment with orientin attenuated S. aureus virulence of in vivo and protected mice against S. aureus-induced lethal pneumonia. These findings indicate that orientin is a potential drug to counter S. aureus infections and limit the development of drug resistance.

1 August 2020 in Biochemical Pharmacology
Verified
Journal Article
Closed access
HZHaitao Zhang
Haitao Zhang
YLYongxin Luan
Yongxin Luan
SJShisong Jing
Shisong Jing
YWYanling Wang
Yanling Wang
ZGZeyuan Gao
Zeyuan Gao
TWTiedong Wang
Tiedong Wang